You are here

Article info

Article menu

Download PDFPDF

XML
Hepatology
Original article
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression

Authors

  • Geula Hanin The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Nadav Yayon The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Yonat Tzur The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Rotem Haviv The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Estelle R Bennett The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Shiran Udi Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Yoganathan R Krishnamoorthy The Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Eleni Kotsiliti Institute of Virology, Technische Universität München and Helmholtz Zentrum München, Munich, Germany PubMed articlesGoogle scholar articles
  • Rivka Zangen The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Ben Efron The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Joseph Tam Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Orit Pappo The Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Eyal Shteyer The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Eli Pikarsky The Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel The Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Mathias Heikenwalder Institute of Virology, Technische Universität München and Helmholtz Zentrum München, Munich, Germany Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany PubMed articlesGoogle scholar articles
  • David S Greenberg The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Hermona Soreq The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Hermona Soreq, The Silberman Institute of Life Sciences and the Edmond and Lily Safra Center for Brain Science, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190401, Israel; hermona.soreq{at}mail.huji.ac.il
View Full Text

Citation

Hanin G, Yayon N, Tzur Y, et al
miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression
Gut 2018;67:1124-1134.

Publication history

  • Received August 12, 2016
  • Revised March 16, 2017
  • Accepted March 18, 2017
  • First published April 5, 2017.
Online issue publication 
August 06, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/